Vontobel Holding Ltd. Novavax Inc Transaction History

Vontobel Holding Ltd.

$30.4 Billion
Q3 2025

A detailed history of Vontobel Holding Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 62,233 shares of NVAX stock, worth $433,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,233

Previous 76,721 18.88%

Holding current value

$433,764

Previous $483,000 11.59%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$6.56 - $9.71 $95,041 - $140,678	-14,488 Reduced 18.88%	62,233 $539,000
Q2 2025 Jul 23, 2025	BUY	$5.43 - $7.74 $4,892 - $6,973	901 Added 1.19%	76,721 $483,000
Q1 2025 Apr 25, 2025	SELL	$6.41 - $10.82 $2.28 Million - $3.84 Million	-354,917 Reduced 82.4%	75,820 $486,000
Q4 2024 Jan 29, 2025	SELL	$7.22 - $14.68 $489,479 - $995,230	-67,795 Reduced 13.6%	430,737 $3.46 Million
Q3 2024 Oct 15, 2024	BUY	$10.71 - $17.11 $2.8 Million - $4.47 Million	261,464 Added 110.29%	498,532 $6.3 Million

Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $84,269 - $454,273	-21,663 Reduced 8.37%	237,068 $3 Million
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $189,541 - $303,468	50,410 Added 24.2%	258,731 $1.24 Million
Q4 2023 Jun 03, 2024	SELL	$4.8 - $7.67 $27,091 - $43,289	-5,644 Reduced 2.64%	208,321 $999,000
Q4 2023 Jan 29, 2024	SELL	$4.8 - $7.67 $27,091 - $43,289	-5,644 Reduced 2.64%	208,321 $999,000
Q3 2023 Jun 03, 2024	BUY	$6.81 - $9.74 $868,261 - $1.24 Million	127,498 Added 147.45%	213,965 $1.55 Million
Q3 2023 Oct 10, 2023	BUY	$6.81 - $9.74 $868,261 - $1.24 Million	127,498 Added 147.45%	213,965 $1.55 Million
Q2 2023 Jun 03, 2024	SELL	$6.67 - $9.52 $553,329 - $789,760	-82,958 Reduced 48.96%	86,467 $642,000
Q2 2023 Jul 24, 2023	SELL	$6.67 - $9.52 $553,329 - $789,760	-82,958 Reduced 48.96%	86,467 $642,000
Q1 2023 Jun 03, 2024	SELL	$5.76 - $12.48 $514,402 - $1.11 Million	-89,306 Reduced 34.52%	169,425 $1.17 Million
Q1 2023 Apr 12, 2023	BUY	$5.76 - $12.48 $440,784 - $955,032	76,525 Added 82.37%	169,425 $1.17 Million
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $10,321 - $29,171	-1,165 Reduced 1.24%	92,900 $955,000
Q3 2022 Nov 04, 2022	BUY	$18.2 - $76.12 $725,069 - $3.03 Million	39,839 Added 73.47%	94,065 $1.71 Million
Q2 2022 Jul 27, 2022	BUY	$36.28 - $75.29 $542,567 - $1.13 Million	14,955 Added 38.08%	54,226 $2.81 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $1.06 Million - $2.17 Million	15,154 Added 62.84%	39,271 $2.94 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $679,258 - $1.1 Million	5,048 Added 26.47%	24,117 $3.73 Million
Q3 2021 Oct 29, 2021	BUY	$177.8 - $270.58 $836,193 - $1.27 Million	4,703 Added 32.74%	19,069 $3.95 Million
Q2 2021 Aug 06, 2021	SELL	$121.0 - $257.67 $1.2 Million - $2.56 Million	-9,954 Reduced 40.93%	14,366 $3 Million
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $814,359 - $2.31 Million	7,208 Added 42.12%	24,320 $4.41 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $1.35 Million - $2.39 Million	17,112 New	17,112 $5.48 Million

Others Institutions Holding NVAX

# of Institutions

310

Shares Held

95.7M

Call Options Held

5.7M

Put Options Held

9.06M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $545M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Novavax Inc Transaction History